regulusrx.com
RG-012 - Regulus Therapeutics
http://regulusrx.com/therapeutic-areas/rg-012-targeting-mir-21-for-alport-syndrome
Biology & Pharmacology. Financials & Filings. Events & Presentations. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. Regulus is developing RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of miR-21 for the treatment of Alport syndrome. Alport syndrome is a life threatening genetic kidney disease with no approved therapies. In preclinical studies, RG-012 has demonstrated potent inhibition of miR-21. ATHENA Natural History Study an...
kidneyurology.org
The Kidney & Urology Foundation of America
http://www.kidneyurology.org/index.php
ORGAN and TISSUE DONATION. NEWS and RECENT EVENTS. And become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected! Our NYC address is. 104 West 40th Street, Suite 500. New York, NY 10018. Our HQ office is. 63 West Main Street, Suite G Freehold, NJ 07728. Kidney and Urology Foundation of America is proud to collaborate with NephCure Kidney International on the NY/NJ Regional Nephrotic Syndrome Symposium. News and Recent Events.